Clinicopathological parameters | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
MEG3 expression | ||||||
High | 1 | |||||
Low | 2.805 | 1.108–7.105 | 0.011 | 2.932 | 1.149–7.484 | 0.018* |
miR-374a-5p expression | ||||||
High | 3.292 | |||||
Low | 1 | 1.206–8.990 | 0.02 | 6.393 | 1.115–36.649 | 0.037* |
Age (years) | ||||||
≤ 60 | 1 | |||||
> 60 | 1.129 | 0.483–2.639 | 0.779 | |||
Gender | ||||||
Male | 1 | |||||
Female | 0.819 | 0.370–2.193 | 0.819 | |||
Tumor location | ||||||
Head, neck | 1 | |||||
Body, tail | 1.227 | 0.698–2.159 | 0.477 | |||
Tumor size (cm) | ||||||
≤ 3 | 0.75 | |||||
> 3 | 1 | 0.336–1.675 | 0.481 | |||
Invasion depth | ||||||
T1 + T2 | 1 | |||||
T3 + T4 | 1.429 | 0.566–3.604 | 0.447 | |||
Lymph nodes metastasis | ||||||
N0 (negative) | 1 | |||||
N1 (positive) | 0.933 | 0.408–2.133 | 0.87 | |||
Clinical stage | ||||||
Early stages (≤ II) | 1 | 1 | ||||
Advanced stages (> II) | 2.55 | 1.112–5.851 | 0.018 | 2.703 | 1.164–6.276 | 0.021* |
Nervous system invasion | ||||||
Negative | 1 | |||||
Positive | 1.048 | 0.447–2.453 | 0.915 |
HR, hazard ratio; 95% CI. 95% confidence interval, *P < 0.05.